Literature DB >> 12860980

Multistep autoactivation of asparaginyl endopeptidase in vitro and in vivo.

Dongtao Ni Li1, Stephen P Matthews, Antony N Antoniou, Daniela Mazzeo, Colin Watts.   

Abstract

Mammalian asparaginyl endopeptidase (AEP) or legumain is a recently discovered lysosomal cysteine protease that specifically cleaves after asparagine residues. How this unusually specific lysosomal protease is itself activated is not fully understood. Using purified recombinant pro-enzyme, we show that activation is autocatalytic, requires sequential removal of C- and N-terminal pro-peptides at different pH thresholds, and is bimolecular. Removal of the N-terminal propeptide requires cleavage after aspartic acid rather than asparagine. Cellular processing, either of exogenously added AEP precursor or of pulse-labeled endogenous precursor, introduces at least one further cleavage to yield the final mature lysosomal enzyme. We also provide evidence that in living cells, there is clear compartmental heterogeneity in terms of AEP activation status. Moreover, we show that human monocyte-derived dendritic cells harbor inactive proforms of AEP that become activated upon maturation of dendritic cells with lipopolysaccharide.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12860980     DOI: 10.1074/jbc.M305930200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  61 in total

1.  Targeting cell surface alpha(v)beta(3) integrin increases therapeutic efficacies of a legumain protease-activated auristatin prodrug.

Authors:  Yuan Liu; Krishna Mohan Bajjuri; Cheng Liu; Subhash C Sinha
Journal:  Mol Pharm       Date:  2011-11-22       Impact factor: 4.939

2.  A dyad of lymphoblastic lysosomal cysteine proteases degrades the antileukemic drug L-asparaginase.

Authors:  Naina Patel; Shekhar Krishnan; Marc N Offman; Marcin Krol; Catherine X Moss; Carly Leighton; Frederik W van Delft; Mark Holland; Jizhong Liu; Seema Alexander; Clare Dempsey; Hany Ariffin; Monika Essink; Tim O B Eden; Colin Watts; Paul A Bates; Vaskar Saha
Journal:  J Clin Invest       Date:  2009-06-08       Impact factor: 14.808

3.  Mechanistic and structural studies on legumain explain its zymogenicity, distinct activation pathways, and regulation.

Authors:  Elfriede Dall; Hans Brandstetter
Journal:  Proc Natl Acad Sci U S A       Date:  2013-06-17       Impact factor: 11.205

4.  Spatiotemporal activation of the C/EBPβ/δ-secretase axis regulates the pathogenesis of Alzheimer's disease.

Authors:  Hualong Wang; Xia Liu; Shengdi Chen; Keqiang Ye
Journal:  Proc Natl Acad Sci U S A       Date:  2018-12-10       Impact factor: 11.205

5.  Structural analysis of asparaginyl endopeptidase reveals the activation mechanism and a reversible intermediate maturation stage.

Authors:  Lixia Zhao; Tian Hua; Christopher Crowley; Heng Ru; Xiangmin Ni; Neil Shaw; Lianying Jiao; Wei Ding; Lu Qu; Li-Wei Hung; Wei Huang; Lei Liu; Keqiang Ye; Songying Ouyang; Genhong Cheng; Zhi-Jie Liu
Journal:  Cell Res       Date:  2014-01-10       Impact factor: 25.617

Review 6.  Proteolysis mediated by cysteine cathepsins and legumain-recent advances and cell biological challenges.

Authors:  Klaudia Brix; Joseph McInnes; Alaa Al-Hashimi; Maren Rehders; Tripti Tamhane; Mads H Haugen
Journal:  Protoplasma       Date:  2014-11-16       Impact factor: 3.356

7.  BDNF inhibits neurodegenerative disease-associated asparaginyl endopeptidase activity via phosphorylation by AKT.

Authors:  Zhi-Hao Wang; Wanqiang Wu; Seong Su Kang; Xia Liu; Zhiping Wu; Junmin Peng; Shan Ping Yu; Fredric P Manfredsson; Ivette M Sandoval; Xuebo Liu; Jian-Zhi Wang; Keqiang Ye
Journal:  JCI Insight       Date:  2018-08-23

8.  Delta-Secretase Phosphorylation by SRPK2 Enhances Its Enzymatic Activity, Provoking Pathogenesis in Alzheimer's Disease.

Authors:  Zhi-Hao Wang; Pai Liu; Xia Liu; Fredric P Manfredsson; Ivette M Sandoval; Shan Ping Yu; Jian-Zhi Wang; Keqiang Ye
Journal:  Mol Cell       Date:  2017-08-17       Impact factor: 17.970

Review 9.  The biology of human lymphoid malignancies revealed by gene expression profiling.

Authors:  Louis M Staudt; Sandeep Dave
Journal:  Adv Immunol       Date:  2005       Impact factor: 3.543

10.  Functional imaging of legumain in cancer using a new quenched activity-based probe.

Authors:  Laura E Edgington; Martijn Verdoes; Alberto Ortega; Nimali P Withana; Jiyoun Lee; Salahuddin Syed; Michael H Bachmann; Galia Blum; Matthew Bogyo
Journal:  J Am Chem Soc       Date:  2012-12-18       Impact factor: 15.419

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.